Actually you are completely wrong on that front. The Ex FDA guy is extremely bullish about Mesoblast’s chances with the resubmission.
Bell Potter may have been given some update, but I am thinking we are still on track for resubmission before the end of this year.
The biggest asset which Mesoblast has is the CHF indication. They have invested more resources in this than any other indication. The upcoming meeting with the FDA for CHF is going to be way more important in my opinion. An accelerated approval for CHF shall instantly make Mesoblast a company worth many many billions. I also look forward to updates soon on CLBP. Lot’s to look forward to.
MESO Nasdaq update, page-3504
-
- There are more pages in this discussion • 2,298 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |